REQUEST A DEMO
Total
USD $0.00
Search more companies

Ksb Pharma Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Ksb Pharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Stores specialized in retail sale of pharmaceuticals, medical and orthopaedic goods;wholesale of pharmaceutical and medical goods;export and import of pharmaceutical and medical goods

Headquarters
B22 Pusat Perkhidmatan Balok
Balok; Pahang; Postal Code: 26100

Contact Details: Purchase the Ksb Pharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ksb Pharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Ksb Pharma Sdn. Bhd. report to view the information.
Incorporation Date:
December 06, 2019
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Akar Pharma Group Sdn. Bhd.
25%
Company Performance
Financial values in the chart are available after Ksb Pharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
9.99%
Total operating revenue
9.99%
Operating profit (EBIT)
106.67%
EBITDA
113.95%
Net Profit (Loss) for the Period
106.29%
Total assets
-0.47%
Total equity
33.25%
Operating Profit Margin (ROS)
2.63%
Net Profit Margin
2.15%
Return on Equity (ROE)
8.83%
Quick Ratio
0.58%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?